COVID-19 Impact on Global Controlled Substances Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-controlled-substances-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Controlled Substances status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Controlled Substances development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Johnson & Johnson
- Pfizer
- Siegfried AG
- GlaxoSmithKline
- Teva Pharmaceuticals
- Mylan
- Takeda Pharmaceutical
- Sun Pharmaceutical
- Daiichi Sankyo
- Akorn Inc
- Tilray
- Medical Marijuana, Inc
- Consort Medical
- Purdue Pharma
- Opioids
- Stimulants
- Depressants
- Marijuana
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Controlled Substances status, future forecast, growth opportunity, key market and key players.
- To present the Controlled Substances development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Controlled Substances Revenue
1.4 Market Analysis by Type
1.4.1 Global Controlled Substances Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Opioids
1.4.3 Stimulants
1.4.4 Depressants
1.4.5 Marijuana
1.4.6 Others
1.5 Market by Application
1.5.1 Global Controlled Substances Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Controlled Substances Industry Impact
1.6.1 How the Covid-19 is Affecting the Controlled Substances Industry
1.6.1.1 Controlled Substances Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Controlled Substances Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Controlled Substances Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Controlled Substances Market Perspective (2015-2026)
2.2 Controlled Substances Growth Trends by Regions
2.2.1 Controlled Substances Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Controlled Substances Historic Market Share by Regions (2015-2020)
2.2.3 Controlled Substances Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Controlled Substances Market Growth Strategy
2.3.6 Primary Interviews with Key Controlled Substances Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Controlled Substances Players by Market Size
3.1.1 Global Top Controlled Substances Players by Revenue (2015-2020)
3.1.2 Global Controlled Substances Revenue Market Share by Players (2015-2020)
3.1.3 Global Controlled Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Controlled Substances Market Concentration Ratio
3.2.1 Global Controlled Substances Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Controlled Substances Revenue in 2019
3.3 Controlled Substances Key Players Head office and Area Served
3.4 Key Players Controlled Substances Product Solution and Service
3.5 Date of Enter into Controlled Substances Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Controlled Substances Historic Market Size by Type (2015-2020)
4.2 Global Controlled Substances Forecasted Market Size by Type (2021-2026)
5 CONTROLLED SUBSTANCES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Controlled Substances Market Size by Application (2015-2020)
5.2 Global Controlled Substances Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Controlled Substances Market Size (2015-2020)
6.2 Controlled Substances Key Players in North America (2019-2020)
6.3 North America Controlled Substances Market Size by Type (2015-2020)
6.4 North America Controlled Substances Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Controlled Substances Market Size (2015-2020)
7.2 Controlled Substances Key Players in Europe (2019-2020)
7.3 Europe Controlled Substances Market Size by Type (2015-2020)
7.4 Europe Controlled Substances Market Size by Application (2015-2020)
8 CHINA
8.1 China Controlled Substances Market Size (2015-2020)
8.2 Controlled Substances Key Players in China (2019-2020)
8.3 China Controlled Substances Market Size by Type (2015-2020)
8.4 China Controlled Substances Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Controlled Substances Market Size (2015-2020)
9.2 Controlled Substances Key Players in Japan (2019-2020)
9.3 Japan Controlled Substances Market Size by Type (2015-2020)
9.4 Japan Controlled Substances Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Controlled Substances Market Size (2015-2020)
10.2 Controlled Substances Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Controlled Substances Market Size by Type (2015-2020)
10.4 Southeast Asia Controlled Substances Market Size by Application (2015-2020)
11 INDIA
11.1 India Controlled Substances Market Size (2015-2020)
11.2 Controlled Substances Key Players in India (2019-2020)
11.3 India Controlled Substances Market Size by Type (2015-2020)
11.4 India Controlled Substances Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Controlled Substances Market Size (2015-2020)
12.2 Controlled Substances Key Players in Central & South America (2019-2020)
12.3 Central & South America Controlled Substances Market Size by Type (2015-2020)
12.4 Central & South America Controlled Substances Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
13.1.3 Johnson & Johnson Controlled Substances Introduction
13.1.4 Johnson & Johnson Revenue in Controlled Substances Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Controlled Substances Introduction
13.2.4 Pfizer Revenue in Controlled Substances Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Siegfried AG
13.3.1 Siegfried AG Company Details
13.3.2 Siegfried AG Business Overview and Its Total Revenue
13.3.3 Siegfried AG Controlled Substances Introduction
13.3.4 Siegfried AG Revenue in Controlled Substances Business (2015-2020)
13.3.5 Siegfried AG Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.4.3 GlaxoSmithKline Controlled Substances Introduction
13.4.4 GlaxoSmithKline Revenue in Controlled Substances Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Teva Pharmaceuticals Controlled Substances Introduction
13.5.4 Teva Pharmaceuticals Revenue in Controlled Substances Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan Controlled Substances Introduction
13.6.4 Mylan Revenue in Controlled Substances Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
13.7.3 Takeda Pharmaceutical Controlled Substances Introduction
13.7.4 Takeda Pharmaceutical Revenue in Controlled Substances Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Details
13.8.2 Sun Pharmaceutical Business Overview and Its Total Revenue
13.8.3 Sun Pharmaceutical Controlled Substances Introduction
13.8.4 Sun Pharmaceutical Revenue in Controlled Substances Business (2015-2020)
13.8.5 Sun Pharmaceutical Recent Development
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Details
13.9.2 Daiichi Sankyo Business Overview and Its Total Revenue
13.9.3 Daiichi Sankyo Controlled Substances Introduction
13.9.4 Daiichi Sankyo Revenue in Controlled Substances Business (2015-2020)
13.9.5 Daiichi Sankyo Recent Development
13.10 Akorn Inc
13.10.1 Akorn Inc Company Details
13.10.2 Akorn Inc Business Overview and Its Total Revenue
13.10.3 Akorn Inc Controlled Substances Introduction
13.10.4 Akorn Inc Revenue in Controlled Substances Business (2015-2020)
13.10.5 Akorn Inc Recent Development
13.11 Tilray
10.11.1 Tilray Company Details
10.11.2 Tilray Business Overview and Its Total Revenue
10.11.3 Tilray Controlled Substances Introduction
10.11.4 Tilray Revenue in Controlled Substances Business (2015-2020)
10.11.5 Tilray Recent Development
13.12 Medical Marijuana, Inc
10.12.1 Medical Marijuana, Inc Company Details
10.12.2 Medical Marijuana, Inc Business Overview and Its Total Revenue
10.12.3 Medical Marijuana, Inc Controlled Substances Introduction
10.12.4 Medical Marijuana, Inc Revenue in Controlled Substances Business (2015-2020)
10.12.5 Medical Marijuana, Inc Recent Development
13.13 Consort Medical
10.13.1 Consort Medical Company Details
10.13.2 Consort Medical Business Overview and Its Total Revenue
10.13.3 Consort Medical Controlled Substances Introduction
10.13.4 Consort Medical Revenue in Controlled Substances Business (2015-2020)
10.13.5 Consort Medical Recent Development
13.14 Purdue Pharma
10.14.1 Purdue Pharma Company Details
10.14.2 Purdue Pharma Business Overview and Its Total Revenue
10.14.3 Purdue Pharma Controlled Substances Introduction
10.14.4 Purdue Pharma Revenue in Controlled Substances Business (2015-2020)
10.14.5 Purdue Pharma Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Controlled Substances Revenue
1.4 Market Analysis by Type
1.4.1 Global Controlled Substances Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Opioids
1.4.3 Stimulants
1.4.4 Depressants
1.4.5 Marijuana
1.4.6 Others
1.5 Market by Application
1.5.1 Global Controlled Substances Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Controlled Substances Industry Impact
1.6.1 How the Covid-19 is Affecting the Controlled Substances Industry
1.6.1.1 Controlled Substances Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Controlled Substances Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Controlled Substances Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Controlled Substances Market Perspective (2015-2026)
2.2 Controlled Substances Growth Trends by Regions
2.2.1 Controlled Substances Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Controlled Substances Historic Market Share by Regions (2015-2020)
2.2.3 Controlled Substances Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Controlled Substances Market Growth Strategy
2.3.6 Primary Interviews with Key Controlled Substances Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Controlled Substances Players by Market Size
3.1.1 Global Top Controlled Substances Players by Revenue (2015-2020)
3.1.2 Global Controlled Substances Revenue Market Share by Players (2015-2020)
3.1.3 Global Controlled Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Controlled Substances Market Concentration Ratio
3.2.1 Global Controlled Substances Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Controlled Substances Revenue in 2019
3.3 Controlled Substances Key Players Head office and Area Served
3.4 Key Players Controlled Substances Product Solution and Service
3.5 Date of Enter into Controlled Substances Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Controlled Substances Historic Market Size by Type (2015-2020)
4.2 Global Controlled Substances Forecasted Market Size by Type (2021-2026)
5 CONTROLLED SUBSTANCES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Controlled Substances Market Size by Application (2015-2020)
5.2 Global Controlled Substances Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Controlled Substances Market Size (2015-2020)
6.2 Controlled Substances Key Players in North America (2019-2020)
6.3 North America Controlled Substances Market Size by Type (2015-2020)
6.4 North America Controlled Substances Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Controlled Substances Market Size (2015-2020)
7.2 Controlled Substances Key Players in Europe (2019-2020)
7.3 Europe Controlled Substances Market Size by Type (2015-2020)
7.4 Europe Controlled Substances Market Size by Application (2015-2020)
8 CHINA
8.1 China Controlled Substances Market Size (2015-2020)
8.2 Controlled Substances Key Players in China (2019-2020)
8.3 China Controlled Substances Market Size by Type (2015-2020)
8.4 China Controlled Substances Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Controlled Substances Market Size (2015-2020)
9.2 Controlled Substances Key Players in Japan (2019-2020)
9.3 Japan Controlled Substances Market Size by Type (2015-2020)
9.4 Japan Controlled Substances Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Controlled Substances Market Size (2015-2020)
10.2 Controlled Substances Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Controlled Substances Market Size by Type (2015-2020)
10.4 Southeast Asia Controlled Substances Market Size by Application (2015-2020)
11 INDIA
11.1 India Controlled Substances Market Size (2015-2020)
11.2 Controlled Substances Key Players in India (2019-2020)
11.3 India Controlled Substances Market Size by Type (2015-2020)
11.4 India Controlled Substances Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Controlled Substances Market Size (2015-2020)
12.2 Controlled Substances Key Players in Central & South America (2019-2020)
12.3 Central & South America Controlled Substances Market Size by Type (2015-2020)
12.4 Central & South America Controlled Substances Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
13.1.3 Johnson & Johnson Controlled Substances Introduction
13.1.4 Johnson & Johnson Revenue in Controlled Substances Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Controlled Substances Introduction
13.2.4 Pfizer Revenue in Controlled Substances Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Siegfried AG
13.3.1 Siegfried AG Company Details
13.3.2 Siegfried AG Business Overview and Its Total Revenue
13.3.3 Siegfried AG Controlled Substances Introduction
13.3.4 Siegfried AG Revenue in Controlled Substances Business (2015-2020)
13.3.5 Siegfried AG Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.4.3 GlaxoSmithKline Controlled Substances Introduction
13.4.4 GlaxoSmithKline Revenue in Controlled Substances Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Teva Pharmaceuticals Controlled Substances Introduction
13.5.4 Teva Pharmaceuticals Revenue in Controlled Substances Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan Controlled Substances Introduction
13.6.4 Mylan Revenue in Controlled Substances Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
13.7.3 Takeda Pharmaceutical Controlled Substances Introduction
13.7.4 Takeda Pharmaceutical Revenue in Controlled Substances Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Details
13.8.2 Sun Pharmaceutical Business Overview and Its Total Revenue
13.8.3 Sun Pharmaceutical Controlled Substances Introduction
13.8.4 Sun Pharmaceutical Revenue in Controlled Substances Business (2015-2020)
13.8.5 Sun Pharmaceutical Recent Development
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Details
13.9.2 Daiichi Sankyo Business Overview and Its Total Revenue
13.9.3 Daiichi Sankyo Controlled Substances Introduction
13.9.4 Daiichi Sankyo Revenue in Controlled Substances Business (2015-2020)
13.9.5 Daiichi Sankyo Recent Development
13.10 Akorn Inc
13.10.1 Akorn Inc Company Details
13.10.2 Akorn Inc Business Overview and Its Total Revenue
13.10.3 Akorn Inc Controlled Substances Introduction
13.10.4 Akorn Inc Revenue in Controlled Substances Business (2015-2020)
13.10.5 Akorn Inc Recent Development
13.11 Tilray
10.11.1 Tilray Company Details
10.11.2 Tilray Business Overview and Its Total Revenue
10.11.3 Tilray Controlled Substances Introduction
10.11.4 Tilray Revenue in Controlled Substances Business (2015-2020)
10.11.5 Tilray Recent Development
13.12 Medical Marijuana, Inc
10.12.1 Medical Marijuana, Inc Company Details
10.12.2 Medical Marijuana, Inc Business Overview and Its Total Revenue
10.12.3 Medical Marijuana, Inc Controlled Substances Introduction
10.12.4 Medical Marijuana, Inc Revenue in Controlled Substances Business (2015-2020)
10.12.5 Medical Marijuana, Inc Recent Development
13.13 Consort Medical
10.13.1 Consort Medical Company Details
10.13.2 Consort Medical Business Overview and Its Total Revenue
10.13.3 Consort Medical Controlled Substances Introduction
10.13.4 Consort Medical Revenue in Controlled Substances Business (2015-2020)
10.13.5 Consort Medical Recent Development
13.14 Purdue Pharma
10.14.1 Purdue Pharma Company Details
10.14.2 Purdue Pharma Business Overview and Its Total Revenue
10.14.3 Purdue Pharma Controlled Substances Introduction
10.14.4 Purdue Pharma Revenue in Controlled Substances Business (2015-2020)
10.14.5 Purdue Pharma Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Controlled Substances Key Market Segments
Table 2. Key Players Covered: Ranking by Controlled Substances Revenue
Table 3. Ranking of Global Top Controlled Substances Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Controlled Substances Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Opioids
Table 6. Key Players of Stimulants
Table 7. Key Players of Depressants
Table 8. Key Players of Marijuana
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Controlled Substances Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Controlled Substances Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Controlled Substances Players to Combat Covid-19 Impact
Table 15. Global Controlled Substances Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Controlled Substances Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Controlled Substances Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Controlled Substances Market Share by Regions (2015-2020)
Table 19. Global Controlled Substances Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Controlled Substances Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Controlled Substances Market Growth Strategy
Table 25. Main Points Interviewed from Key Controlled Substances Players
Table 26. Global Controlled Substances Revenue by Players (2015-2020) (Million US$)
Table 27. Global Controlled Substances Market Share by Players (2015-2020)
Table 28. Global Top Controlled Substances Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Controlled Substances as of 2019)
Table 29. Global Controlled Substances by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Controlled Substances Product Solution and Service
Table 32. Date of Enter into Controlled Substances Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 35. Global Controlled Substances Market Size Share by Type (2015-2020)
Table 36. Global Controlled Substances Revenue Market Share by Type (2021-2026)
Table 37. Global Controlled Substances Market Size Share by Application (2015-2020)
Table 38. Global Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 39. Global Controlled Substances Market Size Share by Application (2021-2026)
Table 40. North America Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Controlled Substances Market Share (2019-2020)
Table 42. North America Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 43. North America Controlled Substances Market Share by Type (2015-2020)
Table 44. North America Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 45. North America Controlled Substances Market Share by Application (2015-2020)
Table 46. Europe Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Controlled Substances Market Share (2019-2020)
Table 48. Europe Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Controlled Substances Market Share by Type (2015-2020)
Table 50. Europe Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Controlled Substances Market Share by Application (2015-2020)
Table 52. China Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 53. China Key Players Controlled Substances Market Share (2019-2020)
Table 54. China Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 55. China Controlled Substances Market Share by Type (2015-2020)
Table 56. China Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 57. China Controlled Substances Market Share by Application (2015-2020)
Table 58. Japan Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Controlled Substances Market Share (2019-2020)
Table 60. Japan Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Controlled Substances Market Share by Type (2015-2020)
Table 62. Japan Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Controlled Substances Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Controlled Substances Market Share (2019-2020)
Table 66. Southeast Asia Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Controlled Substances Market Share by Type (2015-2020)
Table 68. Southeast Asia Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Controlled Substances Market Share by Application (2015-2020)
Table 70. India Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 71. India Key Players Controlled Substances Market Share (2019-2020)
Table 72. India Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 73. India Controlled Substances Market Share by Type (2015-2020)
Table 74. India Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 75. India Controlled Substances Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Controlled Substances Market Share (2019-2020)
Table 78. Central & South America Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Controlled Substances Market Share by Type (2015-2020)
Table 80. Central & South America Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Controlled Substances Market Share by Application (2015-2020)
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Product
Table 85. Johnson & Johnson Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 86. Johnson & Johnson Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Siegfried AG Company Details
Table 93. Siegfried AG Business Overview
Table 94. Siegfried AG Product
Table 95. Siegfried AG Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 96. Siegfried AG Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Product
Table 100. GlaxoSmithKline Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 101. GlaxoSmithKline Recent Development
Table 102. Teva Pharmaceuticals Company Details
Table 103. Teva Pharmaceuticals Business Overview
Table 104. Teva Pharmaceuticals Product
Table 105. Teva Pharmaceuticals Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 106. Teva Pharmaceuticals Recent Development
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Product
Table 110. Mylan Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 111. Mylan Recent Development
Table 112. Takeda Pharmaceutical Company Details
Table 113. Takeda Pharmaceutical Business Overview
Table 114. Takeda Pharmaceutical Product
Table 115. Takeda Pharmaceutical Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 116. Takeda Pharmaceutical Recent Development
Table 117. Sun Pharmaceutical Business Overview
Table 118. Sun Pharmaceutical Product
Table 119. Sun Pharmaceutical Company Details
Table 120. Sun Pharmaceutical Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 121. Sun Pharmaceutical Recent Development
Table 122. Daiichi Sankyo Company Details
Table 123. Daiichi Sankyo Business Overview
Table 124. Daiichi Sankyo Product
Table 125. Daiichi Sankyo Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 126. Daiichi Sankyo Recent Development
Table 127. Akorn Inc Company Details
Table 128. Akorn Inc Business Overview
Table 129. Akorn Inc Product
Table 130. Akorn Inc Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 131. Akorn Inc Recent Development
Table 132. Tilray Company Details
Table 133. Tilray Business Overview
Table 134. Tilray Product
Table 135. Tilray Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 136. Tilray Recent Development
Table 137. Medical Marijuana, Inc Company Details
Table 138. Medical Marijuana, Inc Business Overview
Table 139. Medical Marijuana, Inc Product
Table 140. Medical Marijuana, Inc Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 141. Medical Marijuana, Inc Recent Development
Table 142. Consort Medical Company Details
Table 143. Consort Medical Business Overview
Table 144. Consort Medical Product
Table 145. Consort Medical Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 146. Consort Medical Recent Development
Table 147. Purdue Pharma Company Details
Table 148. Purdue Pharma Business Overview
Table 149. Purdue Pharma Product
Table 150. Purdue Pharma Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 151. Purdue Pharma Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 1. Controlled Substances Key Market Segments
Table 2. Key Players Covered: Ranking by Controlled Substances Revenue
Table 3. Ranking of Global Top Controlled Substances Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Controlled Substances Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Opioids
Table 6. Key Players of Stimulants
Table 7. Key Players of Depressants
Table 8. Key Players of Marijuana
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Controlled Substances Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Controlled Substances Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Controlled Substances Players to Combat Covid-19 Impact
Table 15. Global Controlled Substances Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Controlled Substances Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Controlled Substances Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Controlled Substances Market Share by Regions (2015-2020)
Table 19. Global Controlled Substances Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Controlled Substances Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Controlled Substances Market Growth Strategy
Table 25. Main Points Interviewed from Key Controlled Substances Players
Table 26. Global Controlled Substances Revenue by Players (2015-2020) (Million US$)
Table 27. Global Controlled Substances Market Share by Players (2015-2020)
Table 28. Global Top Controlled Substances Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Controlled Substances as of 2019)
Table 29. Global Controlled Substances by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Controlled Substances Product Solution and Service
Table 32. Date of Enter into Controlled Substances Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 35. Global Controlled Substances Market Size Share by Type (2015-2020)
Table 36. Global Controlled Substances Revenue Market Share by Type (2021-2026)
Table 37. Global Controlled Substances Market Size Share by Application (2015-2020)
Table 38. Global Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 39. Global Controlled Substances Market Size Share by Application (2021-2026)
Table 40. North America Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Controlled Substances Market Share (2019-2020)
Table 42. North America Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 43. North America Controlled Substances Market Share by Type (2015-2020)
Table 44. North America Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 45. North America Controlled Substances Market Share by Application (2015-2020)
Table 46. Europe Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Controlled Substances Market Share (2019-2020)
Table 48. Europe Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Controlled Substances Market Share by Type (2015-2020)
Table 50. Europe Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Controlled Substances Market Share by Application (2015-2020)
Table 52. China Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 53. China Key Players Controlled Substances Market Share (2019-2020)
Table 54. China Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 55. China Controlled Substances Market Share by Type (2015-2020)
Table 56. China Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 57. China Controlled Substances Market Share by Application (2015-2020)
Table 58. Japan Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Controlled Substances Market Share (2019-2020)
Table 60. Japan Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Controlled Substances Market Share by Type (2015-2020)
Table 62. Japan Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Controlled Substances Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Controlled Substances Market Share (2019-2020)
Table 66. Southeast Asia Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Controlled Substances Market Share by Type (2015-2020)
Table 68. Southeast Asia Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Controlled Substances Market Share by Application (2015-2020)
Table 70. India Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 71. India Key Players Controlled Substances Market Share (2019-2020)
Table 72. India Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 73. India Controlled Substances Market Share by Type (2015-2020)
Table 74. India Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 75. India Controlled Substances Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Controlled Substances Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Controlled Substances Market Share (2019-2020)
Table 78. Central & South America Controlled Substances Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Controlled Substances Market Share by Type (2015-2020)
Table 80. Central & South America Controlled Substances Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Controlled Substances Market Share by Application (2015-2020)
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Product
Table 85. Johnson & Johnson Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 86. Johnson & Johnson Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Siegfried AG Company Details
Table 93. Siegfried AG Business Overview
Table 94. Siegfried AG Product
Table 95. Siegfried AG Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 96. Siegfried AG Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Product
Table 100. GlaxoSmithKline Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 101. GlaxoSmithKline Recent Development
Table 102. Teva Pharmaceuticals Company Details
Table 103. Teva Pharmaceuticals Business Overview
Table 104. Teva Pharmaceuticals Product
Table 105. Teva Pharmaceuticals Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 106. Teva Pharmaceuticals Recent Development
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Product
Table 110. Mylan Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 111. Mylan Recent Development
Table 112. Takeda Pharmaceutical Company Details
Table 113. Takeda Pharmaceutical Business Overview
Table 114. Takeda Pharmaceutical Product
Table 115. Takeda Pharmaceutical Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 116. Takeda Pharmaceutical Recent Development
Table 117. Sun Pharmaceutical Business Overview
Table 118. Sun Pharmaceutical Product
Table 119. Sun Pharmaceutical Company Details
Table 120. Sun Pharmaceutical Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 121. Sun Pharmaceutical Recent Development
Table 122. Daiichi Sankyo Company Details
Table 123. Daiichi Sankyo Business Overview
Table 124. Daiichi Sankyo Product
Table 125. Daiichi Sankyo Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 126. Daiichi Sankyo Recent Development
Table 127. Akorn Inc Company Details
Table 128. Akorn Inc Business Overview
Table 129. Akorn Inc Product
Table 130. Akorn Inc Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 131. Akorn Inc Recent Development
Table 132. Tilray Company Details
Table 133. Tilray Business Overview
Table 134. Tilray Product
Table 135. Tilray Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 136. Tilray Recent Development
Table 137. Medical Marijuana, Inc Company Details
Table 138. Medical Marijuana, Inc Business Overview
Table 139. Medical Marijuana, Inc Product
Table 140. Medical Marijuana, Inc Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 141. Medical Marijuana, Inc Recent Development
Table 142. Consort Medical Company Details
Table 143. Consort Medical Business Overview
Table 144. Consort Medical Product
Table 145. Consort Medical Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 146. Consort Medical Recent Development
Table 147. Purdue Pharma Company Details
Table 148. Purdue Pharma Business Overview
Table 149. Purdue Pharma Product
Table 150. Purdue Pharma Revenue in Controlled Substances Business (2015-2020) (Million US$)
Table 151. Purdue Pharma Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Controlled Substances Market Share by Type: 2020 VS 2026
Figure 2. Opioids Features
Figure 3. Stimulants Features
Figure 4. Depressants Features
Figure 5. Marijuana Features
Figure 6. Others Features
Figure 7. Global Controlled Substances Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Controlled Substances Report Years Considered
Figure 12. Global Controlled Substances Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Controlled Substances Market Share by Regions: 2020 VS 2026
Figure 14. Global Controlled Substances Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Controlled Substances Market Share by Players in 2019
Figure 17. Global Top Controlled Substances Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Controlled Substances as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Controlled Substances Revenue in 2019
Figure 19. North America Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Johnson & Johnson Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Pfizer Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 30. Siegfried AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Siegfried AG Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 34. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Teva Pharmaceuticals Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 36. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Mylan Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 38. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Takeda Pharmaceutical Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 40. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sun Pharmaceutical Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 42. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Daiichi Sankyo Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 44. Akorn Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Akorn Inc Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 46. Tilray Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Tilray Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 48. Medical Marijuana, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Medical Marijuana, Inc Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 50. Consort Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Consort Medical Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 52. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Purdue Pharma Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Figure 1. Global Controlled Substances Market Share by Type: 2020 VS 2026
Figure 2. Opioids Features
Figure 3. Stimulants Features
Figure 4. Depressants Features
Figure 5. Marijuana Features
Figure 6. Others Features
Figure 7. Global Controlled Substances Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Controlled Substances Report Years Considered
Figure 12. Global Controlled Substances Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Controlled Substances Market Share by Regions: 2020 VS 2026
Figure 14. Global Controlled Substances Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Controlled Substances Market Share by Players in 2019
Figure 17. Global Top Controlled Substances Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Controlled Substances as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Controlled Substances Revenue in 2019
Figure 19. North America Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Controlled Substances Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Johnson & Johnson Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Pfizer Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 30. Siegfried AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Siegfried AG Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 34. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Teva Pharmaceuticals Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 36. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Mylan Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 38. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Takeda Pharmaceutical Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 40. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sun Pharmaceutical Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 42. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Daiichi Sankyo Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 44. Akorn Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Akorn Inc Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 46. Tilray Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Tilray Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 48. Medical Marijuana, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Medical Marijuana, Inc Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 50. Consort Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Consort Medical Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 52. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Purdue Pharma Revenue Growth Rate in Controlled Substances Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed